Choice and Doses of Antibacterial Agents for Cement Spacers in Treatment of Prosthetic Joint Infections: Review of Published Studies | Zendy

Dmitri Iarikov | Zendy; Hany W. Demian | Zendy; Daniel B. Rubin | Zendy; John Alexander | Zendy; Sumathi Nambiar | Zendy

Open Access

Choice and Doses of Antibacterial Agents for Cement Spacers in Treatment of Prosthetic Joint Infections: Review of Published Studies

Author(s) -

Dmitri Iarikov,

Hany W. Demian,

Daniel B. Rubin,

John Alexander,

Sumathi Nambiar

Publication year - 2012

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cis735

Subject(s) - medicine , antibiotics , vancomycin , dose , clinical trial , bone cement , arthroplasty , antibacterial agent , surgery , intensive care medicine , staphylococcus aureus , cement , bacteria , microbiology and biotechnology , biology , history , genetics , archaeology

Addition of antibacterial drugs to interim antibacterial cement spacers (ACSs) is considered to be standard of care for surgical revision in prosthetic joint infections (PJIs). We reviewed published studies evaluating the choice and doses of antibacterials in spacers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research